Gerresheimer Holds Its Wwn In Difficult Environment

Date: 17 July 2009
Source: Gerresheimer
Sales in the first half of 2009 (excluding Technical Plastics) at prior year level Growth in the pharma business Sales decline in the cyclical segments of cosmetics and laboratory glassware In the first half of 2009, Gerresheimer AG achieved sales at the prior year level despite the continuing worldwide economic crisis.

This result was mainly attributable to sales growth for pharmaceutical packaging and systems, with which Gerresheimer today makes more than 70% of Group sales. In contrast, sales declines were recorded in the more cyclical segments of cosmetics and laboratory glassware. In comparison with the prior year, sales in the second quarter of 2009 declined by 4.3% on a nominal basis to €264.4m and, excluding the Technical Plastics business just sold, by 2.2% to €251.6m. The operating margin (adjusted EBITDA margin) excluding the business just sold reached a high level in the second quarter of 2009 at 18.9%. For the year as a whole, Gerresheimer expects the sales trend excluding Technical Plastics to be +1% to -3% with an adjusted EBITDA margin of 18.0% to 18.5%.
In the course of its continued focus on the markets of pharma & life science the sale of the Technical Plastics business was successfully completed as per July 1, 2009. The transaction price including debts taken over was around €12m.
“Growth in our core markets of pharma & life science has been and remains the basis of our profitable business development. This applies all the more at a time of economic crisis,” says Dr. Axel Herberg, CEO of Gerresheimer AG. “With the successful sale of the peripheral business of Technical Plastics we have taken another important step in focusing the business,” Herberg adds.
Growth for pharmaceutical products
Regardless of the continued trend towards inventory reductions by some pharma companies, Gerresheimer achieved sales growth with products for the pharma industry once again in the second quarter of 2009. Major contributions were made by Medical Plastic Systems, which continue to be a particular growth generator, and good sales of pharmaceutical primary packaging such as ampoules and vials in Europe and China. Installation of the third RTF® syringe line was completed according to plan so that customer-specific validations could be commenced.
As in the first quarter, however, continuing weak demand in the cosmetics segment led to a decline in sales of cosmetic packaging. A similar situation applies for laboratory glassware products, where a temporary sales decline was experienced because of inventory reductions and purchasing cautiousness by customers.
Outlook for 2009
Despite the imponderable factors with regard to further world economic development Gerresheimer continues to expect growth in the field of pharmaceutical packaging and systems. In the more cyclical segments cosmetics and laboratory glassware, Gerresheimer experienced a marked decline in demand in the first half year. Forecasts for the further course of the financial year are difficult. Gerresheimer AG does not however assume any short-term recovery of these markets. The sound balance sheet and long term financing structure as well as a good operating performance will enable Gerresheimer to continue the growth strategy in the pharma & life science segment going forward.
About Gerresheimer
Gerresheimer employs around 10,000 people in 40 locations in Europe, America and Asia. In the financial year 2008, worldwide sales totaled €1.06bn. The product portfolio ranges from pharmaceutical vials made of glass and plastic through to complex drug-delivery systems for the pharma & life science industry. These include sterile syringes, inhalers and other system-based approaches for safe dosage and application of medications. The Group enjoys a leading position in markets which are characterized by high technical and regulatory barriers.
Burkhard Lingenberg
Director Corporate Communication & Marketing
Telephone +49 211 6181-250
Telefax +49 211 6181-241

600450 Gerresheimer Holds Its Wwn In Difficult Environment
Date: 17 July 2009
Source: Gerresheimer

See more news about:

Others also read

We sincerely thank all our members, friends and visitors for being part of GlassOnWeb and its success during 2009.
For further upscaling, the plant has provision for a second float line which can support an additional 850 tonnes per day.  With an aim to further strengthen its leadership position in the glass industry, the Rs15bn.
A prestigious international prize states the poetic beauty and the architectural value of “Tiberio's Baths” in Panticosa (Spain), the new health and wellbeing centre in the heart of the Spanish Pyrenees made entirely using special glass blocks with a trapezoidal section.
During the annual Dujat December Dinner on Thursday 10 December 2009, Minister for Economic Affairs, Ms.
A team of researchers from the University of Vigo, Rutgers University in the United States and Imperial College London, in the United Kingdom, has developed "laser spinning", a novel method of producing glass nanofibres with materials.
Chicago — December 17, 2009 — Designers and engineers examined the product pages on nearly one million times in 2009 in hopes of finding the right materials or technologies for their projects.

Add new comment